Stoke Therapeutics CMO Barry Ticho sells 5,545 shares for $169,164.19

• Stoke Therapeutics Chief Medical Officer Barry Ticho sold 5,545 common shares on Sept. 1, 2026.
• Sales priced at USD 30.51 to USD 31.06 a share.
• Directly held stake fell to 20,110 shares following the transactions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Stoke Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001780088-26-000021), on September 03, 2026, and is solely responsible for the information contained therein.